Cited by 108Pharmacogenetics and Drug MetabolismNeurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase

Open access

Kosten, Thomas R., Wu, Guiying, Huang, Wen, Harding, Mark J., Hamon, Sara C., Lappalainen, Jaakko, Nielsen, David A.·2013·Biological Psychiatry

DOI 10.1016/j.biopsych.2012.07.011PMC PMC3514624

Open this paper in CoChat — free account

Abstract

Background Disulfiram has been an effective cocaine addiction pharmacotherapy, and one of its possible mechanisms of efficacy is through copper chelation and inhibition of an enzyme involved in catecholamine metabolism, dopamine β-hydroxylase (DβH), which converts dopamine to norepinephrine. A variant in the gene encoding DβH leads to reduced DβH activity, and as such, disulfiram might not be an effective treatment of cocaine dependence for individuals with this variant. This study explored that potential matching. Methods Seventy-four cocaine- and opioid-codependent (DSM-V) subjects were stabilized on methadone for 2 weeks and subsequently randomized into disulfiram (250 mg/day, n = 34) and placebo groups (n = 40) for 10 weeks. We genotyped the DBH gene polymorphism, -1021C/T (rs1611115), that reduces DβH enzyme levels and evaluated its role for increasing cocaine free urines with disulfiram. Results With repeated measures analysis of variance, corrected for population structure, disulfiram pharmacotherapy reduced cocaine-positive urines from 80% to 62% (p = .0001), and this disulfiram efficacy differed by DBH genotype group. Patients with the normal DβH level genotype dropped from 84% to 56% on disulfiram (p = .0001), whereas those with the low DBH level genotype showed no disulfiram effect. Conclusions This study indicates that the DBH genotype of a patient could be used to identify a subset of individuals for which disulfiram treatment might be an effective pharmacotherapy for cocaine dependence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2012.07.011

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

3 retracted

Antidepressants for cocaine dependence
de Lima, M. S., Farrell, M., Reisser, A. A. L., & Soares, B. G. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002950 · Cited by 80
Retracted
Carbamazepine for cocaine dependence
Reisser, A. A. L., Lima, M., Soares, B., & Farrell, M. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002023 · Cited by 45
Retracted
Dopamine agonists for cocaine dependence
Soares, B. G., Reisser, A. A. L., Farrell, M., & de Lima, M. S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003352.pub2 · Cited by 10
Retracted
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Inference of Population Structure Using Multilocus Genotype Data
Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,871
Inferring weak population structure with the assistance of sample group information
HUBISZ, M. J., FALUSH, D., STEPHENS, M., & PRITCHARD, J. K. (2009) · Molecular Ecology Resources · doi:10.1111/j.1755-0998.2009.02591.x · Cited by 3,475
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · cited 6×
“00005] but did not differ for those having the CT or TT enotypes [F (1,234) 1.”
Influential
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615
The genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099
Efficacy of Disulfiram and Cognitive Behavior Therapy in Cocaine-DependentOutpatients
Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J. M., & Rounsaville, B. J. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.264 · Cited by 415
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram.
Carroll, K., Nich, C., Ball, S., McCance, E., & Rounsavile, B. J. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9357137.x · Cited by 411
Dopamine supersensitivity correlates with D2 High states, implying many paths to psychosis
Seeman, P. M., Weinshenker, D., Quirion, R., Srivastava, L. K., Bhardwaj, S. K., Grandy, D. K., Premont, R. T., Sotnikova, T. D., Boksa, P., El-Ghundi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409766102 · Cited by 353
There and Back Again: A Tale of Norepinephrine and Drug Addiction
Weinshenker, D., & Schroeder, J. P. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301263 · Cited by 347
Pharmacogenetics of Psychotropic Drug Response
Malhotra, A. K., Murphy, G. M., & Kennedy, J. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.780 · Cited by 299
Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19
de León, J., Armstrong, S. C., & Cozza, K. L. (2005) · Psychosomatics · doi:10.1176/appi.psy.47.1.75 · Cited by 299
Pharmacogenetics of Antidepressant Medication Intolerance
Murphy, G. M., Kremer, C. M. E., Rodrigues, H. E., & Schatzberg, A. F. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1830 · Cited by 284
A Quantitative-Trait Analysis of Human Plasma–Dopamine β-Hydroxylase Activity: Evidence for a Major Functional Polymorphism at the DBH Locus
Zabetian, C. P., Anderson, G., Buxbaum, S. G., Elston, R. C., Ichinose, H., Nagatsu, T., Kim, K., Kim, C., Malison, R. T., Gelernter, J. E., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318198 · Cited by 268
How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals.
Weisner, C., Matzger, H., & Kaskutas, L. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00438.x · Cited by 247
A National 5-Year Follow-up of Treatment Outcomes for Cocaine Dependence
Simpson, D. D., Joe, G. W., & Broome, K. M. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.538 · Cited by 243
Disulfiram treatment for cocaine dependence in methadone‐maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance‐Katz, E. F., Frankforter, T. L., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522198.x · Cited by 229
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs
Rogers, J. F., Nafziger, A. N., & Bertino, J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01363-3 · Cited by 217
Proportioning Whole-Genome Single-Nucleotide–Polymorphism Diversity for the Identification of Geographic Population Structure and Genetic Ancestry
Lao, Ó., van Duijn, K., Kersbergen, P., de Knijff, P., & Kayser, M. (2006) · The American Journal of Human Genetics · doi:10.1086/501531 · Cited by 180
A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia
Cubells, J. F., Kranzler, H. R., McCance‐Katz, E. F., Anderson, G. M., Malison, R. T., Price, L. H., & Gelernter, J. E. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000657 · Cited by 179
Serum Dopamine-β-Hydroxylase Activity: Sibling-Sibling Correlation
Weinshilboum, R. M., Raymond, F. A., Elveback, L. R., & Weidman, W. H. (1973) · Science · doi:10.1126/science.181.4103.943 · Cited by 175
Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals—A genetic study
Oxenstierna, G., Edman, G., Iselius, L., Oreland, L., Ross, S. B., & Sedvall, G. (1986) · Journal of Psychiatric Research · doi:10.1016/0022-3956(86)90020-8 · Cited by 174
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.
Hartel, D. M., Schoenbaum, E. E., Selwyn, P. A., Kline, J. D., Davenny, K., Klein, R. S., & Friedland, G. H. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.1.83 · Cited by 170
Human genetics of plasma dopamine ?-hydroxylase activity: applications to research in psychiatry and neurology
Cubells, J. F., & Zabetian, C. P. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1840-8 · Cited by 168
Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial
George, T. P., Chawarski, M. C., Pakes, J., Carroll, K. M., Kosten, T. R., & Schottenfeld, R. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00310-8 · Cited by 159
Self-citation
Serum Dopamine-βHydroxylase Activity in the Affective Psychoses and Schizophrenia
Meltzer, H. Y. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770050047007 · Cited by 144
Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation
Cubells, J. F., van Kammen, D. P., Kelley, M. E., Anderson, G. M., O’Connor, D. T., Price, L. H., Malison, R. T., Rao, P. A., Kobayashi, K., Nagatsu, T., et al. (1998) · Human Genetics · doi:10.1007/s004390050736 · Cited by 133
Dopamine β-Hydroxylase Knockout Mice have Alterations in Dopamine Signaling and are Hypersensitive to Cocaine
Schank, J. R., Ventura, R., Puglisi‐Allegra, S., Alcaro, A., Cole, C. D., Liles, L. C., Seeman, P. M., & Weinshenker, D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301000 · Cited by 129
Disulfiram Attenuates Drug-Primed Reinstatement of Cocaine Seeking via Inhibition of Dopamine β-Hydroxylase
Schroeder, J. P., Cooper, D. A., Schank, J. R., Lyle, M. A., Gaval‐Cruz, M., Ogbonmwan, Y. E., Pozdeyev, N. V., Freeman, K. G., Iuvone, P. M., Edwards, G. L., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.127 · Cited by 122
Cocaine use and HIV risk behavior in methadone maintenance patients
Bux, D. A., Lamb, R. J., & Iguchi, M. Y. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)01058-s · Cited by 113
Dopamine agonists for the treatment of cocaine dependence
Minozzi, S., Amato, L., Pani, P. P., Solimini, R., Vecchi, S., Crescenzo, F. D., Zuccaro, P., & Davoli, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003352.pub4 · Cited by 108
Disulfiram effects on acute cocaine administration
McCance‐Katz, E. F., Kosten, T. R., & Jatlow, P. L. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00050-7 · Cited by 106
Self-citation
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis
Yao, L., Fan, P., Arolfo, M. P., Jiang, Z., Olive, M. F., Zablocki, J. A., Sun, H.-L., Chu, N., Lee, J., Kim, H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2200 · Cited by 105
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
Weinshenker, D., Miller, N. S., Blizinsky, K. D., Laughlin, M. L., & Palmiter, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212519999 · Cited by 103
Emerging pharmacological strategies in the fight against cocaine addiction
Sofuoglu, M., & Kosten, T. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.1.91 · Cited by 101
Self-citation
Genetic control of plasma dopamine- β -hydroxylase
Ross, S. B., Wetterberg, L., & Myrhed, M. (1973) · Life Sciences · doi:10.1016/0024-3205(73)90056-8 · Cited by 99
Effects of dopamine β-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice
Bourdélat-Parks, B. N., Anderson, G. M., Donaldson, Z. R., Weiss, J. M., Bonsall, R. W., Emery, M., Liles, L. C., & Weinshenker, D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0139-8 · Cited by 97
Catecholamine modulatory effects of nepicastat (RS‐25560‐197), a novel, potent and selective inhibitor of dopamine‐β‐hydroxylase
Stanley, W. C., Li, B., Bonhaus, D. W., Johnson, L. G., Lee, K., Porter, S., Walker, K. A. M., Martinez, G., Eglen, R. M., Whiting, R. L., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701315 · Cited by 93
Antecedents and Consequences of Cocaine Abuse among Opioid Addicts
Kosten, T. R., Rounsaville, B. J., & Kleber, H. D. (1988) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198803000-00006 · Cited by 88
Self-citation
The Structure of Linkage Disequilibrium at the DBH Locus Strongly Influences the Magnitude of Association between Diallelic Markers and Plasma Dopamine β-Hydroxylase Activity
Zabetian, C. P., Buxbaum, S. G., Elston, R. C., Köhnke, M. D., Anderson, G. M., Gelernter, J. E., & Cubells, J. F. (2003) · The American Journal of Human Genetics · doi:10.1086/375499 · Cited by 87
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users
Meandzija, B., O’Connor, P. G., Fitzgerald, B. J., Rounsaville, B. J., & Kosten, T. R. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90092-2 · Cited by 79
Self-citation
Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans
Hameedi, F. A., Rosen, M. I., McCance‐Katz, E. F., McMahon, T. J., Price, L. H., Jatlow, P. I., Woods, S. W., & Kosten, T. R. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00361-6 · Cited by 74
Self-citation
Disulfiram effects on responses to intravenous cocaine administration
Baker, J. R., Jatlow, P. I., & McCance‐Katz, E. F. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.08.016 · Cited by 73
A genotype-controlled analysis of plasma dopamine β-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function
Köhnke, M. D., Zabetian, C. P., Anderson, G., Kolb, W., Gaertner, I., Buchkremer, G., Vonthein, R., Schick, S., Lutz, U. C., Köhnke, A. M., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01427-0 · Cited by 73
Chronic disulfiram treatment effects on intranasal cocaine administration: Initial results
McCance‐Katz, E. F., Kosten, T. R., & Jatlow, P. I. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00506-4 · Cited by 72
Self-citation
Manual-Guided Psychosocial Treatment
Carroll, K. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220041007 · Cited by 70
Disulfiram and Diethyldithiocarbamate Intoxication Affects the Storage and Release of Striatal Dopamine
Vaccari, A., Saba, P., Ruiu, S., Collu, M., & Devoto, P. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0147 · Cited by 70
Genotype-controlled analysis of plasma dopamine β-hydroxylase activity in psychotic unipolar major depression
Cubells, J. F., Price, L. H., Meyers, B. S., Anderson, G. M., Zabetian, C. P., Alexopoulos, G. S., Nelson, J. C., Sanacora, G., Kirwin, P. D., Carpenter, L. L., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01349-x · Cited by 61
Possible control of dopamine β-hydroxylase via a codominant mechanism associated with the polymorphic (GT) n repeat at its gene locus in healthy individuals
Wei, J., Ramchand, C. N., & Hemmings, G. P. (1996) · Human Genetics · doi:10.1007/s004390050310 · Cited by 61
Methadone-Related Deaths in Palm Beach County
Wolf, B. C., Lavezzi, W. A., Sullivan, L., & Flannagan, L. M. (2004) · Journal of Forensic Sciences · doi:10.1520/jfs2003221 · Cited by 54
Clinical Characteristics of Emotionally Disturbed Boys with Very Low Activities of Dopamine-β-hydroxylase
Rogeness, G. A., Hernández, J. M., Macedo, C. A., MITCHELL, E. L., AMRUNG, S. A., & Harris, W. R. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1097/00004583-198403000-00013 · Cited by 54
The long-term outcomes of drug use by methadone maintenance patients
BOVASSO, G. B., & Cacciola, J. (2003) · The Journal of Behavioral Health Services & Research · doi:10.1007/bf02287318 · Cited by 51
Predicting Cocaine Use Among Methadone Patients: Analysis of Findings From a National Study
Dunteman, G. H., Condelli, W. S., & Fairbank, J. A. (1992) · Psychiatric Services · doi:10.1176/ps.43.6.608 · Cited by 50
Near-Zero Plasma Dopamine-β-Hydroxylase and Conduct Disorder in Emotionally Disturbed Boys
Rogeness, G. A., Hernández, J. M., Macedo, C. A., AMRUNG, S. A., & Hoppe, S. K. (1986) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(10)60012-x · Cited by 47
CSF Dopamine β-Hydroxylase in Schizophrenia
Sternberg, D. E. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060041005 · Cited by 45
Dopamine agonists for the treatment of cocaine dependence
Amato, L., Minozzi, S., Pani, P. P., Solimini, R., Vecchi, S., Zuccaro, P., & Davoli, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003352.pub3 · Cited by 44
DBH gene variants that cause low plasma dopamine β hydroxylase with or without a severe orthostatic syndrome
Deinum, J., Steenbergen-Spanjers, G. C. H., Jansen, M., Boomsma, F., Lenders, J. W. M., van Ittersum, F. J., Hück, N., van den Heuvel, L. P., & Wevers, R. A. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.009282 · Cited by 44
Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers
Jönsson, E. G., Bah, J., Melke, J., Jamra, R. A., Schumacher, J. H., Westberg, L., Ivo, R., Cichon, S., Propping, P., Nöthen, M. M., et al. (2004) · BMC Psychiatry · doi:10.1186/1471-244x-4-4 · Cited by 43
CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures
van Kammen, D. P., Kelley, M. E., Gilbertson, M. W., Gurklis, J. A., & O'Connor, D. T. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.372 · Cited by 42
Changes in HIV Risk Behaviors Among Cocaine-Using Methadone Patients
Magura, S., Rosenblum, A., & Rodriguez, E. M. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n04_07 · Cited by 41
Low dopamine-beta-hydroxylase: A biological sequela of abuse and neglect?
Galvin, M. R., Shekhar, A., Simon, J. R., Stilwell, B. M., Eyck, R. L. T., Laite, G., Karwisch, G. A., & Blix, S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90002-7 · Cited by 39
Serum dopamine‐β‐hydroxylase activity in clinical subtypes of depression
Sapru, M. K., Rao, B. S. S., & Channabasavanna, S. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb03008.x · Cited by 39
The effect of increased cocaine use on drug treatment
Black, J. L., Dolan, M. P., Penk, W. E., Robinowitz, R., & DeFord, H. A. (1987) · Addictive Behaviors · doi:10.1016/0306-4603(87)90042-6 · Cited by 36
Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression
Mód, L., Rihmer, Z., Magyar, I., Arató, M., Alföldi, A., & Bagdy, G. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90127-7 · Cited by 36
Diagnoses, Catecholamine Metabolism, and Plasma Dopamine-β-Hydroxylase
Rogeness, G. A., Maas, J. W., Javors, M. A., Macedo, C. A., Harris, W. R., & Hoppe, S. K. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198801000-00019 · Cited by 35
Correlation of Plasma Dopamine β-hydroxylase Activity with Polymorphisms in DBH Gene: A Study on Eastern Indian Population
Bhaduri, N., & Mukhopadhyay, K. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9256-8 · Cited by 34
Quantitative Fluorescent-PCR Detection of Sex Chromosome Aneuploidies and AZF Deletions/Duplications
Plaseski, T., Noveski, P., Trivodalieva, S., Efremov, G. D., & Plaseska‐Karanfilska, D. (2008) · Genetic Testing · doi:10.1089/gte.2008.0068 · Cited by 33
TREATING COCAINE-USING METHADONE PATIENTS: PREDICTORS OF OUTCOMES IN A PSYCHOSOCIAL CLINICAL TRIAL
Magura, S., Rosenblum, A., Fong, C., Villano, C. L., & Richman, B. L. (2002) · Substance Use & Misuse · doi:10.1081/ja-120016225 · Cited by 33
Plasma dopamine-β-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys
Rogeness, G. A., Javors, M. A., Maas, J. W., Macedo, C. A., & Fischer, C. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90058-8 · Cited by 28
The Pharmacogenetics of Major Depression: Past, Present, and Future
Laje, G., & McMahon, F. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.016 · Cited by 26
Factors Associated with Client-Reported HIV Infection Among Clients Entering Methadone Treatment
MacGowan, R. J., Fichtner, R. R., Swanson, N., Collier, C., Kroliczak, A., & Cole, G. E. (1997) · AIDS Education and Prevention · doi:10.1521/aeap.1997.9.3.205 · Cited by 20
TaqI polymorphic sites at the human dopamine β-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia
Wei, J., Ramchand, C. N., & Hemmings, G. P. (1998) · Psychiatric Genetics · doi:10.1097/00041444-199800810-00003 · Cited by 16
Antidepressants for cocaine dependence (Withdrawn Paper. 2010, art no. CD002950)
de Lima, M. S., Farrell, M., Reisser, A. A. L., & Soares, B. G. (2010) · Research Portal (King's College London) · Cited by 16
Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals
Jiang, W., Ramchand, C. N., & Hemmings, G. P. (1997) · Human Molecular Genetics · Cited by 15
Psychotherapeutic Treatment of Cocaine Abuse: Models for Its Evaluation Alone and In Combination With Pharmacotherapy
Carroll, K. M. (1993) · PsycEXTRA Dataset · doi:10.1037/e495932006-009 · Cited by 12
Carbamazepine for cocaine dependence (Withdrawn Paper. 2009, art. no. CD002023)
Reisser, A. A. L., de Lima, M. S., Soares, B. G. D. O., & Farrell, M. (2009) · Research Portal (King's College London) · Cited by 7

Flagged first, then by citations

Sorted by citations

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169
Comparison of Treatments for Cocaine Use Disorder Among Adults: A Systematic Review and Meta-analysis
Bentzley, B. S., Han, S. S., Neuner, S., Humphreys, K., Kampman, K. M., & Halpern, C. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8049 · Cited by 161
Pharmacotherapy for Cocaine Use Disorder—a Systematic Review and Meta-analysis
Chan, B., Kondo, K., Freeman, M., Ayers, C., Montgomery, J., & Kansagara, D. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05074-8 · Cited by 150
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
Lei, Y., Tang, L., Chen, Q., Wu, L., He, W., Tu, D., Wang, S., Chen, Y., Liu, S., Xie, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34671-1 · Cited by 104
Addiction pharmacogenetics
Patriquin, M. A., Bauer, I. E., Soares, J. C., Graham, D. P., & Nielsen, D. A. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000095 · Cited by 89
Self-citation

See all 108

Authors: Kosten, T. R., Wu, G., Huang, W., Harding, M. J., Hamon, S. C., Lappalainen, J., & Nielsen, D. A.
Affiliations: Michael E. DeBakey VA Medical Center (US)
Rockefeller University (US)
Yale University (US)
Corresponding author: Nielsen, David A.
ORCID: Kosten, Thomas R.
Wu, Guiying
Hamon, Sara C.
Nielsen, David A.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2013-02
Volume: 73
Issue: 3
Pages: 219-224
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2012.07.011
PMC: PMC3514624
OpenAlex: W2092220167
Cited by: 108
References: 80
Citations by year: 2026: 4 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 6 · 2017: 4 · 2016: 8 · 2015: 15 · 2014: 14 · 2013: 13
FWCI: 15.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (P50DA018197)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords: disulfiram, cocaine dependence, dopamine beta-hydroxylase, pharmacogenetics, methadone maintenance treatment, copper chelation, catecholamine metabolism, treatment response
MeSH terms: Adult, Disulfiram, Dopamine beta-Hydroxylase, Drug Therapy, Combination, Female, Genotype, Humans, Male, Methadone, Middle Aged, Opioid-Related Disorders, Treatment Outcome, Cocaine-Related Disorders, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks